✦ LIBER ✦

An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin

✍ Scribed by C. Kondo; M. Atsukawa; A. Tsubota; N. Itokawa; T. Fukuda; Y. Matsushita; H. Kidokoro; T. Kobayashi; Y. Narahara; K. Nakatsuka; H. Kanazawa; C. Sakamoto

Book ID: 117947763
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 180 KB
Volume: 19
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2011.01584.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of pegylated interferon plus ri

Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case–control study

✍ Naoki Hiramatsu; Yuko Inoue; Tsugiko Oze; Nao Kurashige; Takayuki Yakushijin; Ki 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 209 KB

457 Retreatment with pegylated interfero

457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

✍ C. Bapin; P. Fabbro-Peray; S. Hachemane; F. Blanc; D. Diaz; P. Pueyo; D. Larrey 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

492 A phase II, placebo-controlled study

492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin

✍ P. Marcellin; Y. Horsmans; F. Nevens; J.D. Grange; J.P. Bronowicki; D. Vetter; R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

814 OLDER AGE IS ASSOCIATED WITH AN IMPA

814 OLDER AGE IS ASSOCIATED WITH AN IMPAIRED RESPONSE TO COMBINATION PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C IN A CASE CONTROL STUDY

✍ M. Puoti; E. Minola; M.G. Antonini; O. Fracassetti; C. Baiguera; V. Ravasio; D. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Virological response and safety outcomes

Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study

✍ Robert G. Gish; Sanjeev Arora; K. Rajender Reddy; David R. Nelson; Christopher O 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 227 KB

A 3-ARM randomized study evaluating the

A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis

✍ Alessandra Mangia; Giovanni Ricci; Nicola Minerva; Marcello Persico; Vito Carret 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB